Envestnet Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Envestnet Asset Management's IRMD Position: Q2 2026 in Review
Envestnet Asset Management increased its iRadimed (IRMD) stake by 4.1% in Q2 2026, buying an estimated $282K and bringing the position to 78,559 shares worth $7.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.
Envestnet Asset Management first reported a position in IRMD in Q3 2016 and has held it in 14 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Envestnet Asset Management held 78,559 shares of iRadimed worth $7.51M as of Q2 2026.
- Envestnet Asset Management bought 3,099 iRadimed shares in Q2 2026, an estimated $282K.
- iRadimed made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2149 holding.
- Envestnet Asset Management first reported a position in iRadimed in Q3 2016 and has held it in 14 quarters since.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.